Nkarta (NKTX) Retained Earnings (2019 - 2026)
Nkarta's (NKTX) quarterly Retained Earnings came in at -$676.1 million in Q1 2026, down 17.34% year-on-year from -$817.9 million in Q1 2025, and down 4.29% quarter-over-quarter from -$648.3 million in Q4 2025.
Nkarta (NKTX) Retained Earnings (2019 - 2026) Analysis & Trends
Nkarta's Retained Earnings history runs 8 years deep, the most recent figure standing at -$676.1 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 17.34% year-over-year to -$676.1 million in Q1 2026; TTM through Mar 2026 was -$676.1 million, a 17.34% decrease from a year earlier, with the FY2025 full-year figure at -$648.3 million, down 19.13% from the prior year.
- Retained Earnings retreated to -$676.1 million in Q1 2026 per NKTX's latest filing, from -$648.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $536000.0 in Q3 2025 and bottomed at -$676.1 million in Q1 2026.
- The 5-year median for Retained Earnings is -$285.4 million (2022), against an average of -$277.7 million.
- Across the five-year window, Retained Earnings plunged 6802900.0% in 2024 and soared 100.1% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$317.9 million in 2022, then jumped by 100.0% to $8000.0 in 2023, then plunged by 6802900.0% to -$544.2 million in 2024, then dropped by 19.13% to -$648.3 million in 2025, then declined by 4.29% to -$676.1 million in 2026.
- Per Business Quant, the three latest NKTX Retained Earnings figures stand at -$676.1 million (Q1 2026), -$648.3 million (Q4 2025), and $536000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | -676.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -676.10 Mn |
| Dec 31, 2025 | -648.31 Mn |
| Sep 30, 2025 | 536,000.00 |
| Jun 30, 2025 | 362,000.00 |
| Mar 31, 2025 | -576.20 Mn |
| Dec 31, 2024 | -544.22 Mn |
| Sep 30, 2024 | -518.30 Mn |
| Jun 30, 2024 | -489.90 Mn |
| Mar 31, 2024 | -127,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | -407.68 Mn |
| Jun 30, 2023 | -601,000.00 |
| Mar 31, 2023 | -174,000.00 |
| Dec 31, 2022 | -317.93 Mn |
| Sep 30, 2022 | -285.35 Mn |
| Jun 30, 2022 | -257.00 Mn |
| Mar 31, 2022 | -606,000.00 |
| Dec 31, 2021 | -204.10 Mn |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | -158.93 Mn |